19.84
price up icon3.98%   0.76
after-market アフターアワーズ: 19.84
loading
前日終値:
$19.08
開ける:
$19.08
24時間の取引高:
1.25M
Relative Volume:
0.70
時価総額:
$1.77B
収益:
$217.42M
当期純損益:
$-243.25M
株価収益率:
-7.0979
EPS:
-2.7952
ネットキャッシュフロー:
$-278.35M
1週間 パフォーマンス:
-2.75%
1か月 パフォーマンス:
-17.78%
6か月 パフォーマンス:
-3.13%
1年 パフォーマンス:
+34.69%
1日の値動き範囲:
Value
$18.82
$19.86
1週間の範囲:
Value
$18.82
$20.71
52週間の値動き範囲:
Value
$12.99
$25.59

Syndax Pharmaceuticals Inc Stock (SNDX) Company Profile

Name
名前
Syndax Pharmaceuticals Inc
Name
セクター
Healthcare (1080)
Name
電話
781-419-1400
Name
住所
730 THIRD AVENUE, NEW YORK, MA
Name
職員
298
Name
Twitter
@syndax
Name
次回の収益日
2026-08-03
Name
最新のSEC提出書
Name
SNDX's Discussions on Twitter

Compare SNDX vs VRTX, REGN, ARGX, RVMD, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
SNDX icon
SNDX
Syndax Pharmaceuticals Inc
19.84 1.77B 217.42M -243.25M -278.35M -2.7952
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
505.75 133.25B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
803.48 82.16B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
851.29 54.80B 4.16B 1.29B 734.26M 19.58
RVMD icon
RVMD
Revolution Medicines Inc
203.71 43.99B 742.00K -1.37B -1.07B -7.0731
ONC icon
ONC
Beone Medicines Ltd Adr
347.48 40.62B 5.76B 514.49M 1.10B 4.4813

Syndax Pharmaceuticals Inc Stock (SNDX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-10-16 再開されました H.C. Wainwright Buy
2025-09-10 再開されました Stifel Buy
2025-09-04 再開されました Guggenheim Buy
2025-08-05 繰り返されました BTIG Research Buy
2025-07-10 開始されました Goldman Buy
2024-10-24 開始されました UBS Buy
2024-06-28 開始されました Jefferies Buy
2024-01-31 ダウングレード Scotiabank Sector Outperform → Sector Perform
2023-12-22 開始されました Mizuho Buy
2023-10-25 開始されました BofA Securities Buy
2023-10-11 開始されました Goldman Buy
2023-07-27 開始されました Scotiabank Sector Outperform
2023-07-11 開始されました Guggenheim Buy
2023-04-17 再開されました BTIG Research Buy
2023-01-31 開始されました Stifel Buy
2023-01-03 開始されました JP Morgan Overweight
2022-07-28 再開されました B. Riley Securities Buy
2022-04-11 開始されました H.C. Wainwright Buy
2022-02-15 開始されました Goldman Buy
2021-06-04 再開されました Robert W. Baird Outperform
2021-05-25 開始されました Citigroup Buy
2021-02-18 開始されました B. Riley Securities Buy
2020-12-03 開始されました Stifel Buy
2020-05-22 アップグレード Citigroup Neutral → Buy
2020-05-22 ダウングレード H.C. Wainwright Buy → Neutral
2020-05-18 ダウングレード Citigroup Buy → Neutral
2020-05-11 繰り返されました H.C. Wainwright Buy
2020-03-04 開始されました Barclays Overweight
2020-01-13 繰り返されました H.C. Wainwright Buy
2019-03-08 繰り返されました H.C. Wainwright Buy
2019-01-04 開始されました Robert W. Baird Outperform
2018-01-05 開始されました B. Riley FBR, Inc. Buy
2017-03-16 開始されました FBR & Co. Outperform
2017-03-02 開始されました Instinet Buy
2016-10-07 開始されました Guggenheim Buy
2016-03-28 開始されました Citigroup Buy
2016-03-28 開始されました JMP Securities Mkt Outperform
2016-03-28 開始されました Morgan Stanley Overweight
すべてを表示

Syndax Pharmaceuticals Inc (SNDX) 最新ニュース

pulisher
Aug 12, 2026

The Technical Signals Behind (SNDX) That Institutions Follow - Stock Traders Daily

Aug 12, 2026
pulisher
Aug 12, 2026

Syndax (SNDX) Sales Nearly Doubled, So Why Did The Stock Fall? - Yahoo Finance

Aug 12, 2026
pulisher
Aug 11, 2026

Syndax (SNDX) Q2 2026 Earnings Call Transcript - AOL.com

Aug 11, 2026
pulisher
Aug 11, 2026

SNDX Maintained by JP Morgan -- Price Target Lowered to $40.00 - GuruFocus

Aug 11, 2026
pulisher
Aug 11, 2026

Syndax Pharmaceuticals (NASDAQ:SNDX) Given New $40.00 Price Target at JPMorgan Chase & Co. - MarketBeat

Aug 11, 2026
pulisher
Aug 11, 2026

J.P. Morgan Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Cuts Target Price to $40 - Moomoo

Aug 11, 2026
pulisher
Aug 11, 2026

Syndax Pharmaceuticals (SNDX) Short Interest & Short Float | Updated Aug 2026 - MarketBeat

Aug 11, 2026
pulisher
Aug 09, 2026

Hennion & Walsh Asset Management Inc. Increases Stock Holdings in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat

Aug 09, 2026
pulisher
Aug 08, 2026

Bank of America Corp DE Decreases Position in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat

Aug 08, 2026
pulisher
Aug 07, 2026

Net margin % of Syndax Pharmaceuticals Inc – HAM:1T3 - TradingView

Aug 07, 2026
pulisher
Aug 07, 2026

Long term debt to total assets ratio of Syndax Pharmaceuticals Inc – HAM:1T3 - TradingView

Aug 07, 2026
pulisher
Aug 07, 2026

Total common shares outstanding of Syndax Pharmaceuticals Inc – HAM:1T3 - TradingView

Aug 07, 2026
pulisher
Aug 07, 2026

Price to sales forward of Syndax Pharmaceuticals Inc – HAM:1T3 - TradingView

Aug 07, 2026
pulisher
Aug 07, 2026

State Street Corporation (SNDX) discloses 5.66M-share, 6.4% holding in Syndax - Stock Titan

Aug 07, 2026
pulisher
Aug 07, 2026

How Surging Revuforj and Niktimvo Sales and Narrowing Losses Could Shape Syndax Pharmaceuticals (SNDX) Investors - Yahoo Finance

Aug 07, 2026
pulisher
Aug 07, 2026

Syndax Pharmaceuticals Inc (1T3) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks

Aug 07, 2026
pulisher
Aug 07, 2026

Earnings Update: Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Just Reported And Analysts Are Trimming Their Forecasts - simplywall.st

Aug 07, 2026
pulisher
Aug 07, 2026

HC Wainwright Brokers Decrease Earnings Estimates for SNDX - MarketBeat

Aug 07, 2026
pulisher
Aug 06, 2026

Syndax Pharmaceuticals Inc (1T3) Q1 2024 Earnings ReportResults, Call & Slides - tipranks.com

Aug 06, 2026
pulisher
Aug 06, 2026

Surging Revenue And Narrower Losses Might Change The Case For Investing In Syndax Pharmaceuticals (SNDX) - webull.com

Aug 06, 2026
pulisher
Aug 06, 2026

What is HC Wainwright's Estimate for SNDX FY2029 Earnings? - MarketBeat

Aug 06, 2026
pulisher
Aug 06, 2026

Syndax Pharmaceuticals (SNDX) Stock Climbs On Revenue Strength As Losses Persist - Sahm

Aug 06, 2026
pulisher
Aug 06, 2026

BofA Securities Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Cuts Target Price to $26 - Moomoo

Aug 06, 2026
pulisher
Aug 05, 2026

A Quick Look at Today's Ratings for Syndax Pharmaceuticals(SNDX.US), With a Forecast Between $26 to $57 - Moomoo

Aug 05, 2026
pulisher
Aug 05, 2026

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - The Manila Times

Aug 05, 2026
pulisher
Aug 05, 2026

Five New Syndax Employees Receive Stock Options With 4-Year Vesting - Stock Titan

Aug 05, 2026
pulisher
Aug 05, 2026

Syndax Pharmaceuticals, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:SNDX) 2026-08-05 - Seeking Alpha

Aug 05, 2026
pulisher
Aug 05, 2026

Syndax Pharmaceuticals, Inc. Stock 12‑Month Price Target Cut to $38.27, Implies 101% Upside - TradingView

Aug 05, 2026
pulisher
Aug 05, 2026

Syndax Pharmaceuticals (NASDAQ:SNDX) Shares Gap Down on Disappointing Earnings - MarketBeat

Aug 05, 2026
pulisher
Aug 05, 2026

SNDX Maintains Rating by HC Wainwright & Co. -- Price Target Low - GuruFocus

Aug 05, 2026
pulisher
Aug 05, 2026

HC Wainwright Has Lowered Expectations for Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price - MarketBeat

Aug 05, 2026
pulisher
Aug 05, 2026

Sei Investments Co. Grows Stake in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat

Aug 05, 2026
pulisher
Aug 05, 2026

Syndax Pharmaceuticals Inc (SNDX) (Q2 2026) Earnings Call Highli - GuruFocus

Aug 05, 2026
pulisher
Aug 05, 2026

SNDX Q2 2026 Sales Surge Highlights Growth Potential Despite Val - GuruFocus

Aug 05, 2026
pulisher
Aug 05, 2026

Syndax Pharmaceuticals Inc (SNDX) (Q2 2026) Earnings Call Highlights: Revenue Surges 92% as ... - Yahoo! Finance Canada

Aug 05, 2026
pulisher
Aug 04, 2026

Syndax Pharmaceuticals Q2 Earnings Call Highlights - marketbeat.com

Aug 04, 2026
pulisher
Aug 04, 2026

Syndax Pharmaceuticals (SNDX) Q2 Revenue Miss Highlights Valuati - GuruFocus

Aug 04, 2026
pulisher
Aug 04, 2026

Is Syndax Pharmaceuticals Inc (SNDX) Facing Value Challenges Aft - GuruFocus

Aug 04, 2026
pulisher
Aug 04, 2026

SNDX: Q2 revenue surged 92% year-over-year, driven by strong Revuforj and Niktimvo growth - TradingView

Aug 04, 2026
pulisher
Aug 04, 2026

Syndax Pharmaceuticals (NASDAQ:SNDX) Releases Quarterly Earnings Results - MarketBeat

Aug 04, 2026
pulisher
Aug 04, 2026

Syndax Pharmaceuticals (SNDX) Reports Q2 Loss, Lags Revenue Estimates - finance.yahoo.com

Aug 04, 2026
pulisher
Aug 04, 2026

Syndax Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 04, 2026
pulisher
Aug 04, 2026

Q2 2026 Syndax Pharmaceuticals Inc Earnings Call Transcript - GuruFocus

Aug 04, 2026
pulisher
Aug 04, 2026

SNDX: Q2 2026 revenue jumped 92% YoY as losses narrowed and pipeline assets advanced - TradingView

Aug 04, 2026
pulisher
Aug 04, 2026

Syndax: Q2 Earnings Snapshot - marketscreener.com

Aug 04, 2026
pulisher
Aug 04, 2026

SNDX Financials: Income Statement, Balance Sheet & Cash Flow | Syndax Pharmaceuticals Inc - Stock Titan

Aug 04, 2026
pulisher
Aug 04, 2026

Syndax Pharmaceuticals | 10-Q: Q2 2026 Earnings Report - Moomoo

Aug 04, 2026
pulisher
Aug 04, 2026

Syndax Reports Second Quarter 2026 Financial Results and Provides Business Update - finance.yahoo.com

Aug 04, 2026
pulisher
Aug 02, 2026

Precision Trading with Syndax Pharmaceuticals Inc. (SNDX) Risk Zones - Stock Traders Daily

Aug 02, 2026
pulisher
Jul 31, 2026

SNDX Stock Price, Quote & Chart - ChartMill

Jul 31, 2026
pulisher
Jul 30, 2026

Syndax Pharmaceuticals, Inc. $SNDX Shares Acquired by Healthcare of Ontario Pension Plan Trust Fund - MarketBeat

Jul 30, 2026

Syndax Pharmaceuticals Inc (SNDX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$63.32
price down icon 0.52%
$58.60
price up icon 0.07%
$36.20
price down icon 0.22%
$123.74
price down icon 2.05%
$228.65
price up icon 0.67%
ONC ONC
$347.48
price down icon 2.40%
大文字化:     |  ボリューム (24 時間):